2018. Development of Bullous Pemphigoid While Receiving PD-1 Checkpoint Inhibitor Nivolumab. SKIN The Journal of Cutaneous Medicine. 2, 3 (Apr. 2018), 175–180. DOI:https://doi.org/10.25251/skin.2.3.5.